Nanoscale Polymer Layers for Wound Bed Modification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current wound healing treatments, including dressings and pharmaceutical modalities, are inadequate for promoting optimal healing in chronic and severe wounds, particularly due to their inability to alter the intrinsic chemistry and structure of the wound bed, leading to impaired re-epithelialization and bacterial resistance issues with silver-based agents.
Innovation Solution
The development of nanoscale polymer layers comprising bioactive agents and microsheets with a nanoscale polymer layer supported on a sacrificial polymer layer, which alter the physical attributes and chemical composition of the wound bed, incorporating antimicrobial compounds like silver nanoparticles to enhance wound healing by modifying the surface properties and providing a stable environment for tissue regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional dressings and pharmaceutical modalities are used to treat chronic wounds, then basic wound care is provided, but they fail to promote optimal healing due to inability to alter intrinsic chemistry and structure of the wound bed
Solution Approach 1:
The patent applies parameter changes by modifying the physical attributes (compliance, topography, charge) and chemical composition of the wound bed through nanoscale polymer layers. These layers alter surface properties at the nanoscale level, creating optimized conditions for cellular activities and wound healing processes that conventional dressings cannot achieve.
Solution Approach 2:
The invention uses composite materials by combining nanoscale polymer layers with bioactive agents and incorporating them into microparticle or nanoparticle formulations. This composite approach allows simultaneous delivery of multiple therapeutic functions (structural modification, chemical alteration, and bioactive agent delivery) that address the limitations of conventional single-function treatments.
2Object-affected harmful factors
If silver-based antimicrobial agents are used to prevent bacterial resistance, then antimicrobial efficacy is achieved, but cytotoxicity issues arise that impede tissue regeneration
Solution Approach 1:
The patent applies local quality by incorporating antimicrobial compounds like silver nanoparticles into nanoscale polymer layers that are applied locally to the wound bed. This localized delivery system provides antimicrobial protection precisely where needed while controlling the concentration and distribution to minimize cytotoxic effects on surrounding healthy tissue.
Solution Approach 2:
The nanoscale polymer layers serve as intermediaries between the antimicrobial agents and the wound bed/tissue. These polymer layers control the release and interaction of antimicrobial compounds, providing sustained antimicrobial efficacy while reducing direct cytotoxic exposure to mammalian cells through the polymer matrix mediation.
3Productivity
If the wound bed intrinsic chemistry and structure are not modified, then treatment simplicity is maintained, but re-epithelialization is impaired and healing is delayed
Solution Approach 1:
The patent applies preliminary action by pre-modifying the wound bed intrinsic chemistry and structure before initiating or continuing wound healing processes. The nanoscale polymer layers are applied to the wound bed to alter its properties in advance, creating an optimized environment that promotes subsequent re-epithelialization and accelerates healing without requiring complex multi-step interventions later.
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
The present invention relates to methods and compositions for wound healing. In particular, the present invention relates to promoting and enhancing wound healing by utilizing cross-linker covalent modification molecules to attach and deliver wound active agents to a wound. In addition, the present invention provides methods and compositions utilizing oppositely charged polyelectrolytes to form a polyelectrolyte layer on a wound surface. The invention further relates to incorporating wound active agents into a polyelectrolyte layer for delivery to a wound.